Copyright
©The Author(s) 2023.
World J Psychiatry. Nov 19, 2023; 13(11): 937-948
Published online Nov 19, 2023. doi: 10.5498/wjp.v13.i11.937
Published online Nov 19, 2023. doi: 10.5498/wjp.v13.i11.937
Table 5 Summary of weight gain (n = 894)
| Total | |
| Baseline (mean ± SD) | 66.21 ± 14.01 |
| 12 weeks (mean ± SD) | 66.21 ± 13.70 |
| Change in body weight (mean ± SD) | 0.20 ± 2.361 |
| Weight gain from baseline ≥ 7%, n (%) | 7 (0.8%) |
- Citation: Wei YM, Wang XJ, Yang XD, Wang CS, Wang LL, Xu XY, Zhao GJ, Li B, Zhu DM, Wu Q, Shen YF. Safety and effectiveness of lurasidone in the treatment of Chinese schizophrenia patients: An interim analysis of post-marketing surveillance. World J Psychiatry 2023; 13(11): 937-948
- URL: https://www.wjgnet.com/2220-3206/full/v13/i11/937.htm
- DOI: https://dx.doi.org/10.5498/wjp.v13.i11.937